Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription


4 Alzheimers Dement
2 Ann Neurol
1 Brain
1 Brain Res
1 Curr Alzheimer Res
1 Dement Geriatr Cogn Disord
1 Exp Gerontol
6 J Alzheimers Dis
3 J Am Geriatr Soc
1 J Biol Chem
3 Neurobiol Aging
2 Neurobiol Dis
1 Neurology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Alzheimers Dement

  1. Register for May AAIC(R) Satellite Symposium and second Latinos & Alzheimer's symposium.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12337.

  2. HANSSON O, Batrla R, Brix B, Carrillo MC, et al
    The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid beta and tau.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12316.
    PubMed         Abstract available

  3. SHI L, Winchester LM, Westwood S, Baird AL, et al
    Replication study of plasma proteins relating to Alzheimer's pathology.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12322.
    PubMed         Abstract available

  4. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Plasma P-tau181 to Abeta42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
    Alzheimers Dement. 2021 Mar 31. doi: 10.1002/alz.12332.
    PubMed         Abstract available

    Ann Neurol

  5. PETERSEN RC, Wiste HJ, Weigand SD, Fields JA, et al
    NIA-AA Alzheimer's Disease Framework: Clinical Characterization of Stages.
    Ann Neurol. 2021 Mar 26. doi: 10.1002/ana.26071.
    PubMed         Abstract available

  6. BUCIUC M, Whitwell JL, Kasanuki K, Graff-Radford J, et al
    Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.
    Ann Neurol. 2021;89:520-533.
    PubMed         Abstract available


  7. RAJNA Z, Mattila H, Huotari N, Tuovinen T, et al
    Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Mar 31. pii: 6206368. doi: 10.1093.
    PubMed         Abstract available

    Brain Res

  8. HILDRE AS, Solvang SH, Aarsland D, Midtun O, et al
    Components of the choline oxidation pathway modify the association between the apolipoprotein epsilon4 gene variant and cognitive decline in patients with dementia.
    Brain Res. 2020;1726:146519.
    PubMed         Abstract available

    Curr Alzheimer Res

  9. WANG Y, Emre C, Gyllenhammar-Schill H, Fjellman K, et al
    Cerebrospinal fluid inflammatory markers in Alzheimer's disease: influence of comorbidities.
    Curr Alzheimer Res. 2021 Mar 30. pii: CAR-EPUB-115096.
    PubMed         Abstract available

    Dement Geriatr Cogn Disord

  10. LESZKO M, Carpenter BD
    Reliability and Validity of the Polish Version of the Alzheimer's Disease Knowledge Scale.
    Dement Geriatr Cogn Disord. 2021 Mar 31:1-9. doi: 10.1159/000514872.
    PubMed         Abstract available

    Exp Gerontol

  11. XIAO QY, Ye TY, Wang XL, Han L, et al
    A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease.
    Exp Gerontol. 2021 Mar 27:111336. doi: 10.1016/j.exger.2021.111336.
    PubMed         Abstract available

    J Alzheimers Dis

  12. DOUROS A, Santella C, Dell'Aniello S, Azoulay L, et al
    Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201534. doi: 10.3233/JAD-201534.
    PubMed         Abstract available

  13. ASHIZAWA T, Igarashi A, Sakata Y, Azuma M, et al
    Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201514. doi: 10.3233/JAD-201514.
    PubMed         Abstract available

  14. KLEIMAN MJ, Barenholtz E, Galvin JE
    Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201377. doi: 10.3233/JAD-201377.
    PubMed         Abstract available

  15. WONG D, Broberg DN, Doad J, Umoh JU, et al
    Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
    J Alzheimers Dis. 2021 Mar 22. pii: JAD201137. doi: 10.3233/JAD-201137.
    PubMed         Abstract available

  16. MORRIS R, Luboff H, Jose RP, Eckhoff K, et al
    Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201551. doi: 10.3233/JAD-201551.
    PubMed         Abstract available

  17. IKEDA S, Mimura M, Ikeda M, Wada-Isoe K, et al
    Economic Burden of Alzheimer's Disease Dementia in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD210075. doi: 10.3233/JAD-210075.
    PubMed         Abstract available

    J Am Geriatr Soc

  18. JENNINGS LA, Hollands S, Keeler E, Wenger NS, et al
    The Effects of Dementia Care Co-Management on Acute Care, Hospice, and Long-Term Care Utilization.
    J Am Geriatr Soc. 2020;68:2500-2507.
    PubMed         Abstract available

  19. MCMASTER M, Kim S, Clare L, Torres SJ, et al
    Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD).
    J Am Geriatr Soc. 2020;68:2629-2637.
    PubMed         Abstract available

  20. REUBEN DB, Gill TM, Stevens A, Williamson J, et al
    D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care.
    J Am Geriatr Soc. 2020;68:2492-2499.
    PubMed         Abstract available

    J Biol Chem

  21. MAULIK M, Vasan L, Bose A, Dutta Chowdhury S, et al
    Amyloid-beta regulates gap junction protein connexin 43 trafficking in cultured primary astrocytes.
    J Biol Chem. 2020;295:15097-15111.
    PubMed         Abstract available


  22. ALEXANDER GC, Emerson S, Kesselheim AS
    Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility.
    JAMA. 2021 Mar 30. pii: 2778191. doi: 10.1001/jama.2021.3854.

    Neurobiol Aging

  23. CASH MK, Rockwood K, Fisk JD, Darvesh S, et al
    Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro.
    Neurobiol Aging. 2021;103:31-41.
    PubMed         Abstract available

  24. NUEBLING GS, Prix C, Brendel M, Beyer L, et al
    Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease.
    Neurobiol Aging. 2021 Feb 28. pii: S0197-4580(21)00076.
    PubMed         Abstract available

  25. GIOVAGNONI C, Ali M, Eijssen LMT, Maes R, et al
    Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach.
    Neurobiol Aging. 2021;102:178-187.
    PubMed         Abstract available

    Neurobiol Dis

  26. WISNIEWSKI T, Drummond E
    APOE-amyloid interaction: Therapeutic targets.
    Neurobiol Dis. 2020;138:104784.
    PubMed         Abstract available

  27. PIMENOVA AA, Goate AM
    Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Neurobiol Dis. 2020;138:104785.
    PubMed         Abstract available


  28. QIAN J, Betensky RA, Hyman BT, Serrano-Pozo A, et al
    Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.
    Neurology. 2021 Mar 26. pii: WNL.0000000000011883.
    PubMed         Abstract available

    PLoS One

  29. BAHADO-SINGH RO, Vishweswaraiah S, Aydas B, Yilmaz A, et al
    Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.
    PLoS One. 2021;16:e0248375.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.